569 related articles for article (PubMed ID: 10499512)
1. Activation of the insulin-like growth factor-binding protein-5 promoter in osteoblasts by cooperative E box, CCAAT enhancer-binding protein, and nuclear factor-1 deoxyribonucleic acid-binding sequences.
Ji C; Chen Y; Centrella M; McCarthy TL
Endocrinology; 1999 Oct; 140(10):4564-72. PubMed ID: 10499512
[TBL] [Abstract][Full Text] [Related]
2. CCAAT/enhancer-binding protein delta activates insulin-like growth factor-I gene transcription in osteoblasts. Identification of a novel cyclic AMP signaling pathway in bone.
Umayahara Y; Ji C; Centrella M; Rotwein P; McCarthy TL
J Biol Chem; 1997 Dec; 272(50):31793-800. PubMed ID: 9395525
[TBL] [Abstract][Full Text] [Related]
3. Promoter-dependent and -independent activation of insulin-like growth factor binding protein-5 gene expression by prostaglandin E2 in primary rat osteoblasts.
McCarthy TL; Casinghino S; Mittanck DW; Ji CH; Centrella M; Rotwein P
J Biol Chem; 1996 Mar; 271(12):6666-71. PubMed ID: 8636084
[TBL] [Abstract][Full Text] [Related]
4. Activation of the insulin-like growth factor binding protein-5 promoter by parathyroid hormone in osteosarcoma cells requires activation of an activated protein-2 element.
Erclik MS; Mitchell J
J Mol Endocrinol; 2005 Jun; 34(3):713-22. PubMed ID: 15956342
[TBL] [Abstract][Full Text] [Related]
5. Time- and dose-related interactions between glucocorticoid and cyclic adenosine 3',5'-monophosphate on CCAAT/enhancer-binding protein-dependent insulin-like growth factor I expression by osteoblasts.
McCarthy TL; Ji C; Chen Y; Kim K; Centrella M
Endocrinology; 2000 Jan; 141(1):127-37. PubMed ID: 10614631
[TBL] [Abstract][Full Text] [Related]
6. Identification of the cAMP response element that controls transcriptional activation of the insulin-like growth factor-I gene by prostaglandin E2 in osteoblasts.
Thomas MJ; Umayahara Y; Shu H; Centrella M; Rotwein P; McCarthy TL
J Biol Chem; 1996 Sep; 271(36):21835-41. PubMed ID: 8702983
[TBL] [Abstract][Full Text] [Related]
7. Members of the nuclear factor 1 transcription factor family regulate rat 3alpha-hydroxysteroid/dihydrodiol dehydrogenase (3alpha-HSD/DD AKR1C9) gene expression: a member of the aldo-keto reductase superfamily.
Hung CF; Penning TM
Mol Endocrinol; 1999 Oct; 13(10):1704-17. PubMed ID: 10517672
[TBL] [Abstract][Full Text] [Related]
8. Identification of elements in the promoter region of the alpha1(I) procollagen gene involved in its up-regulated expression in systemic sclerosis.
Hitraya EG; Varga J; Artlett CM; Jiménez SA
Arthritis Rheum; 1998 Nov; 41(11):2048-58. PubMed ID: 9811061
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of insulin-like growth factor-binding protein-5 by prostaglandin E2 in osteoblast cells.
Pash JM; Canalis E
Endocrinology; 1996 Jun; 137(6):2375-82. PubMed ID: 8641189
[TBL] [Abstract][Full Text] [Related]
10. Identification of an osteogenic protein-1 (bone morphogenetic protein-7)-responsive element in the promoter of the rat insulin-like growth factor-binding protein-5 gene.
Yeh LC; Lee JC
Endocrinology; 2000 Sep; 141(9):3278-86. PubMed ID: 10965899
[TBL] [Abstract][Full Text] [Related]
11. Involvement of CCAAT enhancer binding protein transcription factors in the regulation of prostaglandin G/H synthase 2 expression by interleukin-1 in osteoblastic MC3T3-E1 cells.
Harrison JR; Kelly PL; Pilbeam CC
J Bone Miner Res; 2000 Jun; 15(6):1138-46. PubMed ID: 10841183
[TBL] [Abstract][Full Text] [Related]
12. SF-1 (steroidogenic factor-1), C/EBPbeta (CCAAT/enhancer binding protein), and ubiquitous transcription factors NF1 (nuclear factor 1) and Sp1 (selective promoter factor 1) are required for regulation of the mouse aldose reductase-like gene (AKR1B7) expression in adrenocortical cells.
Aigueperse C; Val P; Pacot C; Darne C; Lalli E; Sassone-Corsi P; Veyssiere G; Jean C; Martinez A
Mol Endocrinol; 2001 Jan; 15(1):93-111. PubMed ID: 11145742
[TBL] [Abstract][Full Text] [Related]
13. Regenerative changes in C/EBP alpha and C/EBP beta expression modulate binding to the C/EBP site in the c-fos promoter.
Diehl AM; Yang SQ
Hepatology; 1994 Feb; 19(2):447-56. PubMed ID: 8294101
[TBL] [Abstract][Full Text] [Related]
14. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
McCarthy TL; Casinghino S; Centrella M; Canalis E
J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403
[TBL] [Abstract][Full Text] [Related]
15. A CACCC box in the proximal exon 2 promoter of the rat insulin-like growth factor I gene is required for basal promoter activity.
Wang X; Talamantez JL; Adamo ML
Endocrinology; 1998 Mar; 139(3):1054-66. PubMed ID: 9492038
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor-1 motif and redundant regulatory elements comprise phenobarbital-responsive enhancer in CYP2B1/2.
Liu S; Park Y; Rivera-Rivera I; Li H; Kemper B
DNA Cell Biol; 1998 May; 17(5):461-70. PubMed ID: 9628589
[TBL] [Abstract][Full Text] [Related]
17. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
[TBL] [Abstract][Full Text] [Related]
18. Delineation of the insulin-responsive sequence in the rat cytosolic aspartate aminotransferase gene: binding sites for hepatocyte nuclear factor-3 and nuclear factor I.
Beurton F; Bandyopadhyay U; Dieumegard B; Barouki R; Aggerbeck M
Biochem J; 1999 Nov; 343 Pt 3(Pt 3):687-95. PubMed ID: 10527950
[TBL] [Abstract][Full Text] [Related]
19. Postnatal liver-specific expression of human insulin-like growth factor-II is highly stimulated by the transcriptional activators liver-enriched activating protein and CCAAT/enhancer binding protein-alpha.
Rodenburg RJ; Teertstra W; Holthuizen PE; Sussenbach JS
Mol Endocrinol; 1995 Apr; 9(4):424-34. PubMed ID: 7659086
[TBL] [Abstract][Full Text] [Related]
20. A Y-box protein is a suppressor factor that decreases thyrotropin receptor gene expression.
Ohmori M; Shimura H; Shimura Y; Kohn LD
Mol Endocrinol; 1996 Jan; 10(1):76-89. PubMed ID: 8838147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
